Enanta Pharmaceuticals (ENTA) Assets Average (2016 - 2025)
Historic Assets Average for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Q3 2025 value amounting to $290.9 million.
- Enanta Pharmaceuticals' Assets Average fell 2497.99% to $290.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $290.9 million, marking a year-over-year decrease of 2497.99%. This contributed to the annual value of $328.7 million for FY2025, which is 2163.99% down from last year.
- Enanta Pharmaceuticals' Assets Average amounted to $290.9 million in Q3 2025, which was down 2497.99% from $312.0 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Assets Average ranged from a high of $478.7 million in Q3 2023 and a low of $290.9 million during Q3 2025
- Over the past 5 years, Enanta Pharmaceuticals' median Assets Average value was $406.2 million (recorded in 2024), while the average stood at $398.3 million.
- As far as peak fluctuations go, Enanta Pharmaceuticals' Assets Average soared by 2587.61% in 2023, and later plummeted by 2497.99% in 2025.
- Over the past 5 years, Enanta Pharmaceuticals' Assets Average (Quarter) stood at $439.7 million in 2021, then fell by 17.79% to $361.5 million in 2022, then increased by 23.21% to $445.4 million in 2023, then dropped by 18.58% to $362.6 million in 2024, then dropped by 19.79% to $290.9 million in 2025.
- Its Assets Average was $290.9 million in Q3 2025, compared to $312.0 million in Q2 2025 and $335.8 million in Q1 2025.